| Literature DB >> 28911543 |
Wenping Xiao1,2, Shiming Li1, Siyu Wang3, Chi-Tang Ho3.
Abstract
Gardenia jasminoides, grown in multiple regions in China, was commonly used as a natural yellow dye but has been one of the popular traditional Chinese medicines since the discovery of its biological property a few decades ago. It has been reported that G. jasminoides possess multiple biological activities, such as antioxidant properties, hypoglycemic effect, inhibition of inflammation, antidepression activity, and improved sleeping quality. In this review, our aim was to have a comprehensive summary of its phytochemistry including the extraction, isolation, and characterization of volatiles and bioactive molecules in G. jasminoides, focusing on the two major phytochemicals, genipin and crocin, which possess potent medicinal properties. Furthermore, this study attempted to establish a structure-activity relationship between the two major series of molecules with two pharmcophores and their biological activities, which would serve further exploration of the properties of phytocompounds in G. jasminoides as potential functional foods and medicines.Entities:
Keywords: Gardenia jasminoides; crocin; genipin; geniposide; iridiod
Mesh:
Substances:
Year: 2016 PMID: 28911543 PMCID: PMC9333430 DOI: 10.1016/j.jfda.2016.11.005
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Extraction method of volatile oil from Gardenia jasminoides.
| Extraction method | Parameters of extraction | Results (%) | Refs |
|---|---|---|---|
| Supercritical fluid extraction (SFE) | Extraction pressure: 36.8 MPa | Linoleic acid, 44; palmitic acid, 26.4; oleic acid, 24.6 | [ |
| Temperature: 49.94°C | 16 major components of the oil extract were characterized | [ | |
| Pressure: 30 MPa | Linoleic acid, 44.38; oleic acid, 24.96; palmitic acid, 24.83; stearic acid, 2.55; linolenic acid, 1.31 | [ | |
| Pressure: 12 MPa or 25 MPa | Oil yield, 12 | [ | |
| Subcritical fluid extraction | Subcritical butane | Fatty acids, 77.6 | [ |
| Ultrasound-assisted extraction | 28 kHz & 100 W | Oil yield, 16.49 | [ |
| Steam distillation | Distilled water | Oil yield, 0.12 | [ |
Iridoids and iridoid glycosides isolated from Gardenia jasminoides.
| No. | Name | Structure | Extraction & isolation | Refs |
|---|---|---|---|---|
| 1 | Geniposide |
| Reflux with 50% ethanol, HSCCC, MSPD | [ |
| 2 | 6β-Hydroxy geniposide |
| Cold percolate with 40% ethanol, macroporous resin HSCCC | [ |
| 3 | Geniposidic acid |
| Cold percolate with 40% ethanol | [ |
| 4 | Gardenoside |
| Cold percolate with 40% ethanol, macroporous resin, HSCCC | [ |
| 5 | 6α-Hydroxy geniposide |
| Reflux with 60% ethanol, Silica gel column, C18 column, preparative HPLC | [ |
| 6 | 6- |
| ||
| 7 | 6- |
| ||
| 8 | 8- |
| ||
| 9 | Shanzhiside |
| ||
| 10 | Gardoside |
| ||
| 11 | 10- |
| ||
| 12 | 6″- |
| ||
| 13 | 6″- |
| ||
| 14 | 6′- |
| Reflux with 90%, 70% EtOH | [ |
| 15 | 6″- |
| 60% EtOH | [ |
| 16 | Genipin 1- |
| ||
| 17 | Genipin 1- |
| ||
| 18 | 6β-Hydroxy genipin |
| ||
| 19 | Genipin |
| ||
| 20 | Gardenoside |
| HPLC–MS | [ |
| 21 | Deacetylasperulosidic acid methyl ester |
| ||
| 22 | Scandoside methyl ester |
| ||
| 23 | 4″- |
| 80% EtOH | [ |
| 24 | 6′- |
| ||
| 25 | Bartsioside |
| ||
| 26 | Gardenal-I |
| EtOH/H2O (9:1) at room temperature | [ |
| 27 | Gardenal-II |
| ||
| 28 | Gardenal-III |
| ||
| 29 | Ixoroside |
| Reflux with 50% aqueous ethanol | [ |
| 30 | (+)-(7 |
| Reflux with 60% EtOH | [ |
| 31 | 10- |
| ||
| 32 | Shanzhiside methyl ester (I) |
| Reflux with 65% EtOH | [ |
| 33 | Phloyoside (II) |
| ||
| 34 | Chlorotuberside (III) |
| ||
| 35 | Penstemonoside (IV) |
|
Crocin and its chain derivatives in Gardenia jasminoides.
| Name | Structure |
|---|---|
| Crocin |
|
|
| |
| Gardecin |
|
Isolation methods of crocin and its chain derivatives.
| Name | Extraction & isolation methods | Refs |
|---|---|---|
| Crocin1 | Temperature 25°C; Time: 1 h; solvent: methanol, ethanol, 1-propanol, 2-propanol | [ |
| Temperature: 60°C; Time: 2 h; Solvent: water | [ | |
| Temperature: 70.4°C; Time: 28.6 min; Solvent: 51.3% ethanol | [ | |
| Crocin1, crocin 2, crocin 3, crocin 4 | Ethanol–water (40%) by cold percolation macroporous resin (HPD-100); HSCCC | [ |
| Crocin1, crocin 2, crocin 3, crocin 4 | Ethanol–water (40%) cold percolation; silica gel & C18 column; macroporous resin (HPD-100) | [ |
| Crocin1, crocin 2, crocin 3, crocin 4; | Ethanol/water (40:60); cold percolation; silica gel column; macroporous resin (HPD-100) | [ |
| Crocetin | Ethanol–water (40%) cold percolation; silica gel; macroporous resin (HPD-100) | [ |
| Crocin1, crocin 2, crocin 3, crocetin | Macroporous resin; C18 | [ |
| Crocin 1, crocin 3, crocetin | 70% ethanol | [ |
Structures of monoterpenoids in Gardenia jasminoides.
| No. | Name | Structures | Refs |
|---|---|---|---|
| 1 | 6′- |
| [ |
| 2 | 6′- |
| |
| 3 | Rehmapicrogenin |
| [ |
| 4 | Jasminoside C |
| |
| 5 | Jasminoside B |
| |
| 6 | Jasminoside G |
| |
| 7 | Jasminoside K |
| [ |
| 8 | Jasminoside I |
| |
| 9 | Jasminoside H |
| |
| 10 | Epi-jasminoside H |
| |
| 11 | 6′- |
| |
| 12 | Jasminoside S |
| [ |
| 13 | Jasminoside J |
| [ |
| 14 | 6′- |
| |
| 15 | 6′- |
| |
| 16 | Jasminoside M |
| |
| 17 | Jasminoside N |
| |
| 18 | 6- |
| |
| 19 | 6- |
| |
| 20 | Jasminoside C |
| |
| 21 | Jasminoside E |
| |
| 22 | Sacranoside B |
| |
| 23 | Jasminodiol |
| [ |
| 24 | Jasminoside H |
| |
| 25 | 6′- |
| |
| 26 | 6′- |
| |
| 27 | Jasminoside I |
|
Figure 1Chemical structure of (+)-(7S,8R,8′R)-lyoniresinol 9-O-β-d-(6″-O-trans-sinapoyl) glucopyranoside.
Different extracts from Gardenia jasminoides and their bioactivities.
|
| Bioactivities | Model | Proposed mechanism | Refs |
|---|---|---|---|---|
| Water extracts | Antioxidant activity |
| [ | |
| Improvement of insulin sensitivity | Exert a peroxisome proliferator activated receptor | [ | ||
| Anti-inflammation |
| Reduce JNK1/2, & p38 MAPKs phosphorylation, & slightly reduce cyclooxygenase (COX)-2 expression in BV-2 cells | [ | |
| Prevention of arteriosclerosis & thrombosis |
| The hot water extracts of | [ | |
| Oil | Antidepressant activity |
| [ | |
| Ethanol extract | Antidepressant activity |
| Associated with the elevated expression of brain-derived neurotrophic factor in the hippocampus | [ |
| Antigastritic activity |
| [ | ||
| Antiangiogenic activity |
| [ | ||
| Genipin | Reduce insulin resistance |
| A close relationship with the improvement of hepatic oxidative stress, mitochondrial dysfunction & insulin signal impairment | [ |
| Antidepressant activity |
| Regulating the glycolysis/gluconeogenesis, TCA cycle & lipid metabolism of liver | [ | |
| Protection of liver damage |
| Antioxidative, antiapoptotic activities, & inhibition of NF-κB nuclear translocation & nuclear p-c-Jun expression | [ | |
| Inhibit gastric lesions |
| Was relevant with the antioxidant activities, acid-neutralizing capacities, & anti- | [ | |
| Antithrombotic effect |
| Inhibition of PLA2 activity | [ | |
| Genotoxicity |
| Damage of DNA in rec assay using V79 cells | [ | |
| Geniposide | Antidiabetes |
| Inhibited the adhesion of monocytes to HUVECs & the expression of CAMs induced by high glucose | [ |
| Anti-inflammatory |
| Reducing the expression of TLR4 by LPS | [ | |
| Antiarthritis |
| Downregulated the expression of p-JNK. | [ | |
|
| Decreased the expression level of TNF-α, IL-1, & IL-6, increasing the production of IL-10 & inhibiting the expression of phospho-p38 (pp38) related proteins in FLS | [ | ||
| Antithrombotic & antiangiogenic |
| Inhibited collagen-induced, but did not inhibit arachidonate-induced, mouse platelet aggregation | [ | |
| Antidepressant activity |
| Increased the levels of serotonin in striatum & hippocampus in mice | [ | |
| Antidepressant activity |
| Monoamine oxidase-B | [ | |
| Effects on AD & PD |
| Increased growth factor signaling & decreases apoptosis | [ | |
| Crocin | Antioxidant |
| [ | |
| Anti-inflammatory |
| Inhibited COX-1 & COX-2 enzymes | [ | |
| Protective of the injured liver |
| [ | ||
| Antihyperlipidemic |
| Selectively inhibited the activity of pancreatic lipase | [ | |
| Crocetin | Antihypertensive & antithrombotic effects |
| Related to the increase in bioavailable NO | [ |
| Prevent insulin resistance |
| [ | ||
| Inhibit retinal damage |
| Inhibited increase in caspase-3 & -9 activities | [ | |
| Alleviate renal dysfunction |
| [ | ||
| Improve the quality of sleep | [ |
AD = Alzheimer’s disease; CAMs = cell adhesion molecules; FLS = Fixed lag; HUVECs = human umbilical vein endothelial cells; IL = interleukin; JNK1/2 = c-Jun N-terminal protein kinase 1 and 2; LPS = lipopolysaccharide; MAPK = mitogen-activated protein kinase; NF-κB = nuclear factor-kappa B; NO = nitric oxide; PD = Parkinson’s disease; PLA2 = phospholipase A2; TCA = tricarboxylic acid; TLR4 = Toll-like receptor 4; TNFα = tumor necrosis factor alpha.